Back to Search
Start Over
Multicriteria optimization achieves superior normal tissue sparing in volumetric modulated arc therapy for gastric cancer.
- Source :
-
BMC cancer [BMC Cancer] 2024 Nov 11; Vol. 24 (1), pp. 1376. Date of Electronic Publication: 2024 Nov 11. - Publication Year :
- 2024
-
Abstract
- Objective: To evaluate the benefits of volumetric modulated arc therapy (VMAT) based on multicriteria optimization (MCO) for gastric cancer patients, particularly the protection of serial organs at risk (OARs) that overlap with the target volume.<br />Methods: MCO and single-criterion optimization (SCO) VMAT plans were conducted among 30 gastric cancer patients, with a prescription dose of 50.4 Gy delivered in 28 fractions. All treatment plans underwent review, and a comparison was made between the active planning time and different dose-volume parameters.<br />Results: Both the MCO and SCO VMAT plans achieved the target dose coverage, with no significant difference in the conformity index (CI) for the planning target volume (PTV), at median CI values of 0.887 and 0.891, respectively (P = 0.417). The MCO plans showed a slight but significant increase in the homogeneity index of the PTV, with a median increase of 0.029 (P < 0.001). Additionally, the MCO plans resulted in a lower D <subscript>2%</subscript> to the small intestine and duodenum, with reductions of 3.43 Gy and 0.3 Gy, respectively (P < 0.05). Furthermore, the D <subscript>max</subscript> to the small intestine correlated moderately with the overlapping volume between the small intestine and the target volume (ρ = 0.42, P = 0.023). Except for the mean dose to the liver, the MCO plans performed better in terms of dose indicators for other OARs. Moreover, compared to the SCO plans, the median active planning time in the MCO plans was significantly reduced by 53.2 min (P < 0.0001).<br />Conclusions: MCO can effectively help the physicians to quickly select an optimal treatment plan for patients with gastric cancer. It has been shown that MCO VMAT plans can significantly reduce the dose to OARs and shorten the active planning time, with acceptable target coverage. In addition, these plans take less dosimetric time, thereby streamlining the treatment planning process.<br />Competing Interests: Declarations Ethics approval and consent to participate This study, conducted in accordance with the Declaration of Helsinki, received approval from the ethics committee of West China Hospital, confirming that informed consent was obtained from all subjects and/or their legal guardians. Consent for publication Not applicable. Competing interests The authors declare no competing interests.<br /> (© 2024. The Author(s).)
Details
- Language :
- English
- ISSN :
- 1471-2407
- Volume :
- 24
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BMC cancer
- Publication Type :
- Academic Journal
- Accession number :
- 39528982
- Full Text :
- https://doi.org/10.1186/s12885-024-13067-y